$OTLKW Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Outlook Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Outlook Therapeutics, Inc.. Get notifications about new insider transactions in Outlook Therapeutics, Inc. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Apr 20 2021 | OTLKW | Outlook Therapeuti ... | Haddadin Yezan Munther | Director | Buy | P | 1.82 | 10,000 | 18,200 | 20,000 | 10 K to 20 K (+100.00 %) |
Apr 20 2021 | OTLKW | Outlook Therapeuti ... | Sukhtian Faisal Ghiath | Director | Buy | P | 1.82 | 10,000 | 18,200 | 20,000 | 10 K to 20 K (+100.00 %) |
Apr 20 2021 | OTLKW | Outlook Therapeuti ... | KENYON LAWRENCE A | CEO, Pres, CFO, Tre ... | Buy | P | 1.83 | 10,000 | 18,300 | 18,926 | 8.9 K to 18.9 K (+112.03 %) |
Mar 26 2021 | OTLKW | Outlook Therapeuti ... | Huang Andong | Director | Option Exercise | A | 2.27 | 20,873 | 47,382 | 20,873 | |
Mar 26 2021 | OTLKW | Outlook Therapeuti ... | Auffarth Gerd | Director | Option Exercise | A | 2.27 | 20,873 | 47,382 | 20,873 | |
Mar 26 2021 | OTLKW | Outlook Therapeuti ... | Gangolli Julian S | Director | Option Exercise | A | 2.27 | 20,873 | 47,382 | 20,873 | |
Mar 26 2021 | OTLKW | Outlook Therapeuti ... | Haddadin Yezan Munther | Director | Option Exercise | A | 2.27 | 20,873 | 47,382 | 20,873 | |
Mar 26 2021 | OTLKW | Outlook Therapeuti ... | Sukhtian Faisal Ghiath | Director | Option Exercise | A | 2.27 | 20,873 | 47,382 | 20,873 | |
Mar 26 2021 | OTLKW | Outlook Therapeuti ... | THURMAN RANDY H | Director | Option Exercise | A | 2.27 | 20,873 | 47,382 | 20,873 | |
Mar 26 2021 | OTLKW | Outlook Therapeuti ... | HILZINGER KURT J | Director | Option Exercise | A | 2.27 | 20,873 | 47,382 | 20,873 | |
Feb 25 2021 | OTLKW | Outlook Therapeuti ... | Evanson Jeff | Chief Commercial Of ... | Sell | S | 2.09 | 8,554 | 17,861 | 1,141,930 | 1.2 M to 1.1 M (-0.74 %) |
Feb 25 2021 | OTLKW | Outlook Therapeuti ... | Dagnon Terry | Chief Operating Off ... | Sell | S | 2.09 | 15,900 | 33,199 | 1,127,857 | 1.1 M to 1.1 M (-1.39 %) |
Feb 17 2021 | OTLKW | Outlook Therapeuti ... | Evanson Jeff | Chief Commercial Of ... | Sell | S | 2.55 | 56,973 | 145,281 | 1,150,484 | 1.2 M to 1.2 M (-4.72 %) |
Feb 17 2021 | OTLKW | Outlook Therapeuti ... | Dagnon Terry | Chief Operating Off ... | Sell | S | 2.55 | 63,700 | 162,435 | 1,143,757 | 1.2 M to 1.1 M (-5.28 %) |
Feb 11 2021 | OTLKW | Outlook Therapeuti ... | Sukhtian Ghiath M. | Director | Grant | A | 1.00 | 1,013,627 | 1,013,627 | 11,834,257 | 10.8 M to 11.8 M (+9.37 %) |
Feb 04 2021 | OTLKW | Outlook Therapeuti ... | Syntone Ventures LLC | 10% Owner | Buy | P | 1.00 | 3,000,000 | 3,000,000 | 19,823,045 | 16.8 M to 19.8 M (+17.83 %) |
Feb 02 2021 | OTLKW | Outlook Therapeuti ... | Sukhtian Ghiath M. | Director | Buy | P | 1.00 | 8,360,000 | 8,360,000 | 10,820,630 | 2.5 M to 10.8 M (+339.75 %) |
Oct 05 2020 | ONS | Outlook Therapeuti ... | Gangolli Julian S | Director | Option Exercise | A | 0.71 | 150,748 | 106,307 | 150,748 | |
Sep 22 2020 | ONS | Outlook Therapeuti ... | Haddadin Yezan Munther | Director | Buy | P | 0.72 | 10,000 | 7,245 | 10,000 | 0 to 10 K |
Sep 17 2020 | ONS | Outlook Therapeuti ... | Sukhtian Faisal Ghiath | Director | Buy | P | 0.67 | 10,000 | 6,731 | 10,000 | 0 to 10 K |
Sep 15 2020 | ONS | Outlook Therapeuti ... | THURMAN RANDY H | Director | Buy | P | 0.62 | 10,000 | 6,200 | 11,875 | 1.9 K to 11.9 K (+533.33 %) |
Jul 28 2020 | ONS | Outlook Therapeuti ... | Syntone Ventures LLC | 10% Owner | Buy | P | 1.22 | 823,045 | 1,000,000 | 16,823,045 | 16 M to 16.8 M (+5.14 %) |
Jul 21 2020 | ONS | Outlook Therapeuti ... | THURMAN RANDY H | Director | Option Exercise | A | 1.58 | 210,000 | 331,800 | 210,000 | |
Jul 21 2020 | ONS | Outlook Therapeuti ... | Sukhtian Faisal Ghiath | Director | Option Exercise | A | 1.58 | 135,000 | 213,300 | 135,000 | |
Jul 21 2020 | ONS | Outlook Therapeuti ... | KENYON LAWRENCE A | CEO, Pres, CFO, Tre ... | Option Exercise | A | 1.58 | 450,000 | 711,000 | 450,000 | |
Jul 21 2020 | ONS | Outlook Therapeuti ... | Huang Andong | Director | Option Exercise | A | 1.58 | 125,000 | 197,500 | 125,000 | |
Jul 21 2020 | ONS | Outlook Therapeuti ... | HILZINGER KURT J | Director | Option Exercise | A | 1.58 | 210,000 | 331,800 | 210,000 | |
Jul 21 2020 | ONS | Outlook Therapeuti ... | Haddadin Yezan Munther | Director | Option Exercise | A | 1.58 | 135,000 | 213,300 | 135,000 | |
Jul 21 2020 | ONS | Outlook Therapeuti ... | Gangolli Julian S | Director | Option Exercise | A | 1.58 | 125,000 | 197,500 | 125,000 | |
Jul 21 2020 | ONS | Outlook Therapeuti ... | Auffarth Gerd | Director | Option Exercise | A | 1.58 | 125,000 | 197,500 | 125,000 | |
Jul 06 2020 | ONS | Outlook Therapeuti ... | Gangolli Julian S | Director | Option Exercise | A | 1.28 | 35,006 | 44,808 | 35,006 | |
Jul 06 2020 | ONS | Outlook Therapeuti ... | Huang Andong | Director | Option Exercise | A | 1.28 | 11,376 | 14,561 | 11,376 | |
Jul 06 2020 | ONS | Outlook Therapeuti ... | Auffarth Gerd | Director | Option Exercise | A | 1.28 | 19,874 | 25,439 | 19,874 | |
Jun 23 2020 | ONS | Outlook Therapeuti ... | Huang Andong | Director | Option Exercise | A | 1.35 | 25,000 | 33,750 | 25,000 | |
Apr 21 2020 | ONS | Outlook Therapeuti ... | Evanson Jeff | Chief Commercial Of ... | Grant | A | 0.00 | 1,207,457 | 0 | 1,207,457 | 0 to 1.2 M |
Apr 21 2020 | ONS | Outlook Therapeuti ... | Dagnon Terry | Chief Operating Off ... | Grant | A | 0.00 | 1,207,457 | 0 | 1,207,457 | 0 to 1.2 M |
Apr 21 2020 | ONS | Outlook Therapeuti ... | Gangolli Julian S | Director | Option Exercise | A | 0.72 | 25,000 | 18,000 | 25,000 | |
Apr 21 2020 | ONS | Outlook Therapeuti ... | Auffarth Gerd | Director | Option Exercise | A | 0.72 | 25,000 | 18,000 | 25,000 | |
Mar 23 2020 | ONS | Outlook Therapeuti ... | BioLexis Pte Ltd. | Director | Option Exercise | M | 0.00 | 68,112 | 0 | 0 | |
Mar 23 2020 | ONS | Outlook Therapeuti ... | BioLexis Pte Ltd. | Director | Option Exercise | A | 0.00 | 68,112 | 0 | 68,112 | |
Mar 23 2020 | ONS | Outlook Therapeuti ... | BioLexis Pte Ltd. | Director | Option Exercise | D | 0.00 | 68,112 | 0 | 0 | |
Mar 23 2020 | ONS | Outlook Therapeuti ... | BioLexis Pte Ltd. | Director | Buy | M | 0.00 | 29,358,621 | 0 | 50,965,058 | 21.6 M to 51 M (+135.88 %) |
Mar 20 2020 | ONS | Outlook Therapeuti ... | KENYON LAWRENCE A | CEO, Pres, CFO, Tre ... | Option Exercise | A | 0.54 | 216,435 | 116,875 | 216,435 | |
Mar 20 2020 | ONS | Outlook Therapeuti ... | Sukhtian Faisal Ghiath | Director | Option Exercise | A | 0.54 | 15,000 | 8,100 | 15,000 | |
Mar 20 2020 | ONS | Outlook Therapeuti ... | HILZINGER KURT J | Director | Option Exercise | A | 0.54 | 15,000 | 8,100 | 15,000 | |
Mar 20 2020 | ONS | Outlook Therapeuti ... | HILZINGER KURT J | Director | Option Exercise | A | 0.54 | 15,000 | 8,100 | 15,000 | |
Mar 20 2020 | ONS | Outlook Therapeuti ... | Haddadin Yezan Munther | Director | Option Exercise | A | 0.54 | 15,000 | 8,100 | 15,000 | |
Mar 20 2020 | ONS | Outlook Therapeuti ... | Haddadin Yezan Munther | Director | Option Exercise | A | 0.54 | 15,000 | 8,100 | 15,000 | |
Mar 20 2020 | ONS | Outlook Therapeuti ... | THURMAN RANDY H | Director | Option Exercise | A | 0.54 | 15,000 | 8,100 | 15,000 | |
Mar 20 2020 | ONS | Outlook Therapeuti ... | THURMAN RANDY H | Director | Option Exercise | A | 0.54 | 15,000 | 8,100 | 15,000 | |
Jan 29 2020 | ONS | Outlook Therapeuti ... | BioLexis Pte Ltd. | Director | Option Exercise | M | 0.23 | 1,282,051 | 297,436 | 0 | |
Jan 29 2020 | ONS | Outlook Therapeuti ... | BioLexis Pte Ltd. | Director | Option Exercise | M | 0.23 | 1,282,051 | 297,436 | 0 | |
Jan 29 2020 | ONS | Outlook Therapeuti ... | BioLexis Pte Ltd. | Director | Option Exercise | M | 0.23 | 2,093,750 | 485,750 | 0 | |
Jan 29 2020 | ONS | Outlook Therapeuti ... | BioLexis Pte Ltd. | Director | Option Exercise | A | 0.23 | 1,282,051 | 297,436 | 1,282,051 | |
Jan 29 2020 | ONS | Outlook Therapeuti ... | BioLexis Pte Ltd. | Director | Option Exercise | D | 7.80 | 1,282,051 | 9,999,998 | 0 | |
Jan 29 2020 | ONS | Outlook Therapeuti ... | BioLexis Pte Ltd. | Director | Option Exercise | A | 0.23 | 1,282,051 | 297,436 | 1,282,051 | |
Jan 29 2020 | ONS | Outlook Therapeuti ... | BioLexis Pte Ltd. | Director | Option Exercise | D | 7.80 | 1,282,051 | 9,999,998 | 0 | |
Jan 29 2020 | ONS | Outlook Therapeuti ... | BioLexis Pte Ltd. | Director | Option Exercise | A | 0.23 | 2,093,750 | 485,750 | 2,039,750 | |
Jan 29 2020 | ONS | Outlook Therapeuti ... | BioLexis Pte Ltd. | Director | Option Exercise | D | 7.20 | 2,093,750 | 15,075,000 | 0 | |
Jan 29 2020 | ONS | Outlook Therapeuti ... | BioLexis Pte Ltd. | Director | Buy | M | 0.23 | 4,657,852 | 1,080,622 | 21,606,437 | 16.9 M to 21.6 M (+27.48 %) |
Jan 06 2020 | ONS | Outlook Therapeuti ... | Haddadin Yezan Munther | Director | Option Exercise | A | 0.88 | 5,980 | 5,233 | 5,980 | |
Dec 31 2019 | ONS | Outlook Therapeuti ... | BioLexis Pte Ltd. | Director | Option Exercise | J | 0.00 | 1,661 | 0 | 68,112 | |
Dec 30 2019 | ONS | Outlook Therapeuti ... | BioLexis Pte Ltd. | Director | Option Exercise | M | 0.23 | 3,636,364 | 843,636 | 0 | |
Dec 30 2019 | ONS | Outlook Therapeuti ... | BioLexis Pte Ltd. | Director | Buy | M | 0.23 | 2,909,091 | 674,909 | 16,948,585 | 14 M to 16.9 M (+20.72 %) |
Oct 07 2019 | ONS | Outlook Therapeuti ... | Haddadin Yezan Munther | Director | Option Exercise | A | 1.40 | 80,176 | 112,246 | 80,176 | |
Oct 07 2019 | ONS | Outlook Therapeuti ... | Haddadin Yezan Munther | Director | Option Exercise | A | 1.40 | 15,000 | 21,000 | 15,000 | |
Oct 07 2019 | ONS | Outlook Therapeuti ... | Thomas Joe | Director | Option Exercise | A | 1.40 | 48,207 | 67,490 | 48,207 | |
Oct 07 2019 | ONS | Outlook Therapeuti ... | Thomas Joe | Director | Option Exercise | A | 1.40 | 15,000 | 21,000 | 15,000 | |
Oct 07 2019 | ONS | Outlook Therapeuti ... | Sukhtian Faisal Ghiath | Director | Option Exercise | A | 1.40 | 86,772 | 121,481 | 86,772 | |
Oct 07 2019 | ONS | Outlook Therapeuti ... | Sukhtian Faisal Ghiath | Director | Option Exercise | A | 1.40 | 15,000 | 21,000 | 15,000 | |
Oct 07 2019 | ONS | Outlook Therapeuti ... | THURMAN RANDY H | Director | Option Exercise | A | 1.40 | 207,036 | 289,850 | 207,036 | |
Oct 07 2019 | ONS | Outlook Therapeuti ... | THURMAN RANDY H | Director | Option Exercise | A | 1.40 | 15,000 | 21,000 | 15,000 | |
Oct 07 2019 | ONS | Outlook Therapeuti ... | HILZINGER KURT J | Director | Option Exercise | A | 1.40 | 60,893 | 85,250 | 60,893 | |
Oct 07 2019 | ONS | Outlook Therapeuti ... | HILZINGER KURT J | Director | Option Exercise | A | 1.40 | 15,000 | 21,000 | 15,000 | |
Sep 30 2019 | ONS | Outlook Therapeuti ... | BioLexis Pte Ltd. | Director | Option Exercise | J | 0.00 | 1,620 | 0 | 66,451 | |
Sep 23 2019 | ONS | Outlook Therapeuti ... | KENYON LAWRENCE A | CEO, Pres, CFO, Tre ... | Sell | S | 1.70 | 1,350 | 2,295 | 80,863 | 82.2 K to 80.9 K (-1.64 %) |
Sep 13 2019 | ONS | Outlook Therapeuti ... | KENYON LAWRENCE A | CEO, Pres, CFO, Tre ... | Option Exercise | A | 1.75 | 450,000 | 787,500 | 450,000 | |
Jul 01 2019 | ONS | Outlook Therapeuti ... | BioLexis Pte Ltd. | Director | Option Exercise | J | 0.00 | 1,581 | 0 | 64,831 | |
Jun 19 2019 | ONS | Outlook Therapeuti ... | BioLexis Pte Ltd. | Director | Option Exercise | M | 2.90 | 3,636,364 | 10,545,456 | 0 | |
Jun 19 2019 | ONS | Outlook Therapeuti ... | BioLexis Pte Ltd. | Director | Buy | M | 0.00 | 2,181,818 | 0 | 14,039,494 | 11.9 M to 14 M (+18.40 %) |
Apr 16 2019 | ONS | Outlook Therapeuti ... | BioLexis Pte Ltd. | Director | Option Exercise | A | 2.90 | 3,636,364 | 10,545,456 | 3,636,364 | |
Apr 16 2019 | ONS | Outlook Therapeuti ... | BioLexis Pte Ltd. | Director | Option Exercise | A | 2.90 | 3,636,364 | 10,545,456 | 3,636,364 | |
Apr 16 2019 | ONS | Outlook Therapeuti ... | BioLexis Pte Ltd. | Director | Grant | A | 2.75 | 3,636,364 | 10,000,001 | 11,857,676 | 8.2 M to 11.9 M (+44.23 %) |
Apr 02 2019 | ONS | Outlook Therapeuti ... | BioLexis Pte Ltd. | Director | Option Exercise | J | 0.00 | 1,542 | 0 | 63,250 | |
Feb 19 2019 | ONS | Outlook Therapeuti ... | KENYON LAWRENCE A | CEO, Pres, CFO, Tre ... | Option Exercise | A | 1.32 | 800,000 | 1,056,000 | 800,000 | |
Feb 19 2019 | ONS | Outlook Therapeuti ... | Bahrt Kenneth | Chief Medical Offic ... | Option Exercise | A | 1.32 | 600,000 | 792,000 | 600,000 | |
Feb 08 2019 | ONS | Outlook Therapeuti ... | KENYON LAWRENCE A | CEO, Pres, CFO, Tre ... | Buy | P | 0.90 | 25,000 | 22,380 | 82,213 | 57.2 K to 82.2 K (+43.70 %) |
Feb 06 2019 | ONS | Outlook Therapeuti ... | HILZINGER KURT J | Director | Buy | P | 0.80 | 5,983 | 4,786 | 184,947 | 179 K to 184.9 K (+3.34 %) |
Feb 05 2019 | ONS | Outlook Therapeuti ... | BioLexis Pte Ltd. | Director | Grant | A | 0.93 | 4,288,624 | 4,000,000 | 65,770,503 | 61.5 M to 65.8 M (+6.98 %) |
Feb 05 2019 | ONS | Outlook Therapeuti ... | BioLexis Pte Ltd. | Director | Grant | A | 0.93 | 4,288,624 | 4,000,000 | 65,770,503 | 61.5 M to 65.8 M (+6.98 %) |
Feb 01 2019 | ONS | Outlook Therapeuti ... | HILZINGER KURT J | Director | Buy | P | 0.77 | 8,200 | 6,314 | 178,964 | 170.8 K to 179 K (+4.80 %) |
Feb 01 2019 | ONS | Outlook Therapeuti ... | HILZINGER KURT J | Director | Buy | P | 0.75 | 6,300 | 4,725 | 170,764 | 164.5 K to 170.8 K (+3.83 %) |
Feb 01 2019 | ONS | Outlook Therapeuti ... | HILZINGER KURT J | Director | Buy | P | 0.72 | 4,890 | 3,521 | 164,464 | 159.6 K to 164.5 K (+3.06 %) |
Jan 29 2019 | ONS | Outlook Therapeuti ... | HILZINGER KURT J | Director | Buy | P | 0.73 | 5,400 | 3,942 | 159,574 | 154.2 K to 159.6 K (+3.50 %) |
Jan 29 2019 | ONS | Outlook Therapeuti ... | HILZINGER KURT J | Director | Buy | P | 0.71 | 15,884 | 11,278 | 154,174 | 138.3 K to 154.2 K (+11.49 %) |
Jan 29 2019 | ONS | Outlook Therapeuti ... | HILZINGER KURT J | Director | Buy | P | 0.69 | 10,828 | 7,471 | 138,290 | 127.5 K to 138.3 K (+8.50 %) |
Jan 24 2019 | ONS | Outlook Therapeuti ... | HILZINGER KURT J | Director | Buy | P | 0.67 | 2,266 | 1,518 | 127,462 | 125.2 K to 127.5 K (+1.81 %) |
Jan 24 2019 | ONS | Outlook Therapeuti ... | HILZINGER KURT J | Director | Buy | P | 0.68 | 10,749 | 7,309 | 125,196 | 114.4 K to 125.2 K (+9.39 %) |
Jan 18 2019 | ONS | Outlook Therapeuti ... | HILZINGER KURT J | Director | Buy | P | 0.69 | 2,300 | 1,587 | 114,447 | 112.1 K to 114.4 K (+2.05 %) |
Jan 18 2019 | ONS | Outlook Therapeuti ... | HILZINGER KURT J | Director | Buy | P | 0.68 | 800 | 544 | 112,147 | 111.3 K to 112.1 K (+0.72 %) |
Jan 17 2019 | ONS | Outlook Therapeuti ... | Mohan Pankaj | Director | Buy | P | 0.68 | 8,000 | 5,440 | 7,064,553 | 7.1 M to 7.1 M (+0.11 %) |
Jan 17 2019 | ONS | Outlook Therapeuti ... | Mohan Pankaj | Director | Buy | P | 0.68 | 8,000 | 5,440 | 7,064,553 | 7.1 M to 7.1 M (+0.11 %) |
Jan 16 2019 | ONS | Outlook Therapeuti ... | HILZINGER KURT J | Director | Buy | P | 0.70 | 2,266 | 1,586 | 111,347 | 109.1 K to 111.3 K (+2.08 %) |
Jan 16 2019 | ONS | Outlook Therapeuti ... | HILZINGER KURT J | Director | Buy | P | 0.71 | 4,399 | 3,123 | 109,081 | 104.7 K to 109.1 K (+4.20 %) |
Jan 11 2019 | ONS | Outlook Therapeuti ... | HILZINGER KURT J | Director | Buy | P | 0.70 | 6,053 | 4,237 | 104,682 | 98.6 K to 104.7 K (+6.14 %) |
Jan 11 2019 | ONS | Outlook Therapeuti ... | HILZINGER KURT J | Director | Buy | P | 0.73 | 2,792 | 2,038 | 98,629 | 95.8 K to 98.6 K (+2.91 %) |
Jan 08 2019 | ONS | Outlook Therapeuti ... | HILZINGER KURT J | Director | Buy | P | 0.65 | 6,410 | 4,167 | 95,837 | 89.4 K to 95.8 K (+7.17 %) |
Jan 08 2019 | ONS | Outlook Therapeuti ... | HILZINGER KURT J | Director | Buy | P | 0.63 | 5,166 | 3,255 | 89,427 | 84.3 K to 89.4 K (+6.13 %) |
Jan 08 2019 | ONS | Outlook Therapeuti ... | HILZINGER KURT J | Director | Buy | P | 0.59 | 6,205 | 3,661 | 84,261 | 78.1 K to 84.3 K (+7.95 %) |
Dec 31 2018 | ONS | Outlook Therapeuti ... | BioLexis Pte Ltd. | Director | Option Exercise | J | 0.00 | 1,505 | 0 | 61,708 | |
Dec 28 2018 | ONS | Outlook Therapeuti ... | HILZINGER KURT J | Director | Buy | P | 0.52 | 11,910 | 6,193 | 60,867 | 49 K to 60.9 K (+24.33 %) |
Dec 28 2018 | ONS | Outlook Therapeuti ... | HILZINGER KURT J | Director | Buy | P | 0.51 | 730 | 372 | 48,957 | 48.2 K to 49 K (+1.51 %) |
Dec 28 2018 | ONS | Outlook Therapeuti ... | HILZINGER KURT J | Director | Buy | P | 0.54 | 5,714 | 3,086 | 48,227 | 42.5 K to 48.2 K (+13.44 %) |
Dec 26 2018 | ONS | Outlook Therapeuti ... | HILZINGER KURT J | Director | Buy | P | 0.66 | 1,113 | 735 | 42,513 | 41.4 K to 42.5 K (+2.69 %) |
Dec 26 2018 | ONS | Outlook Therapeuti ... | HILZINGER KURT J | Director | Buy | P | 0.65 | 3,600 | 2,340 | 41,400 | 37.8 K to 41.4 K (+9.52 %) |
Dec 21 2018 | ONS | Outlook Therapeuti ... | THURMAN RANDY H | Director | Buy | P | 0.68 | 15,000 | 10,251 | 15,000 | 0 to 15 K |
Dec 06 2018 | ONS | Outlook Therapeuti ... | BioLexis Pte Ltd. | Director | Grant | A | 0.93 | 4,288,624 | 4,000,000 | 57,193,255 | 52.9 M to 57.2 M (+8.11 %) |
Nov 13 2018 | ONS | Oncobiologics, Inc ... | Mohan Pankaj | Director | Option Exercise | A | 0.89 | 114,157 | 101,600 | 114,157 | |
Nov 13 2018 | ONS | Oncobiologics, Inc ... | Windisch Joerg | Director | Option Exercise | A | 0.89 | 130,465 | 116,114 | 130,465 | |
Nov 13 2018 | ONS | Oncobiologics, Inc ... | HILZINGER KURT J | Director | Option Exercise | A | 0.89 | 203,851 | 181,427 | 203,851 | |
Nov 13 2018 | ONS | Oncobiologics, Inc ... | THURMAN RANDY H | Director | Option Exercise | A | 0.89 | 567,522 | 505,095 | 567,522 | |
Nov 09 2018 | ONS | Oncobiologics, Inc ... | BioLexis Pte Ltd. | Director | Grant | A | 0.93 | 8,577,248 | 7,999,999 | 52,904,631 | 44.3 M to 52.9 M (+19.35 %) |
Oct 24 2018 | ONS | Oncobiologics, Inc ... | Bahrt Kenneth | Chief Medical Offic ... | Option Exercise | A | 0.90 | 450,000 | 405,000 | 450,000 | |
Oct 24 2018 | ONS | Oncobiologics, Inc ... | MCANDREW STEPHEN J | SVP Bus. Strat. & D ... | Option Exercise | A | 0.90 | 200,000 | 180,000 | 200,000 | |
Oct 02 2018 | ONS | Oncobiologics, Inc ... | BioLexis Pte Ltd. | 10% Owner | Option Exercise | J | 0.00 | 1,648 | 0 | 60,383 | |
Sep 25 2018 | ONS | Oncobiologics, Inc ... | THURMAN RANDY H | Director | Option Exercise | A | 0.92 | 15,000 | 13,733 | 15,000 | |
Sep 25 2018 | ONS | Oncobiologics, Inc ... | HILZINGER KURT J | Director | Option Exercise | A | 0.92 | 15,000 | 13,733 | 15,000 | |
Sep 25 2018 | ONS | Oncobiologics, Inc ... | Windisch Joerg | Director | Option Exercise | A | 0.92 | 15,000 | 13,733 | 15,000 | |
Sep 25 2018 | ONS | Oncobiologics, Inc ... | Mohan Pankaj | Director | Option Exercise | A | 0.92 | 15,000 | 13,733 | 15,000 | |
Sep 18 2018 | ONS | Oncobiologics, Inc ... | KENYON LAWRENCE A | CEO, Pres, CFO, Tre ... | Sell | S | 0.87 | 10,100 | 8,807 | 57,213 | 67.3 K to 57.2 K (-15.00 %) |
Aug 03 2018 | ONS | Oncobiologics, Inc ... | KENYON LAWRENCE A | CEO, Pres, CFO, Tre ... | Option Exercise | A | 0.86 | 500,000 | 430,000 | 500,000 | |
Jul 20 2018 | ONS | Oncobiologics, Inc ... | GMS Tenshi Holdings Pte. Ltd | Director | Option Exercise | A | 0.00 | 58,735 | 0 | 58,735 | |
Jul 20 2018 | ONS | Oncobiologics, Inc ... | GMS Tenshi Holdings Pte. Ltd | Director | Option Exercise | D | 0.00 | 58,735 | 0 | 0 | |
Jul 20 2018 | ONS | Oncobiologics, Inc ... | GMS Tenshi Holdings Pte. Ltd | Director | Option Exercise | A | 0.00 | 6,526 | 0 | 58,735 | |
Jun 28 2018 | ONS | Oncobiologics, Inc ... | THURMAN RANDY H | Director | Option Exercise | A | 0.88 | 100,000 | 88,000 | 100,000 | |
Jun 27 2018 | ONS | Oncobiologics, Inc ... | Bahrt Kenneth | Chief Medical Offic ... | Sell | S | 0.85 | 7,700 | 6,507 | 47,120 | 54.8 K to 47.1 K (-14.05 %) |
Jun 25 2018 | ONS | Oncobiologics, Inc ... | GMS Tenshi Holdings Pte. Ltd | Director | Option Exercise | C | 0.00 | 208,836 | 0 | 52,209 | |
Jun 25 2018 | ONS | Oncobiologics, Inc ... | GMS Tenshi Holdings Pte. Ltd | Director | Option Exercise | J | 0.00 | 6,367 | 0 | 261,045 | |
Jun 25 2018 | ONS | Oncobiologics, Inc ... | GMS Tenshi Holdings Pte. Ltd | Director | Option Exercise | J | 0.00 | 4,678 | 0 | 254,678 | |
Jun 25 2018 | ONS | Oncobiologics, Inc ... | GMS Tenshi Holdings Pte. Ltd | Director | Option Exercise | A | 0.98 | 10,256,410 | 10,000,000 | 20,512,820 | |
Jun 25 2018 | ONS | Oncobiologics, Inc ... | GMS Tenshi Holdings Pte. Ltd | Director | Option Exercise | A | 0.98 | 10,256,410 | 10,000,000 | 10,256,410 | |
Jun 25 2018 | ONS | Oncobiologics, Inc ... | GMS Tenshi Holdings Pte. Ltd | Director | Buy | C | 0.00 | 31,572,617 | 0 | 44,327,383 | 12.8 M to 44.3 M (+247.54 %) |
Jun 25 2018 | ONS | Oncobiologics, Inc ... | GMS Tenshi Holdings Pte. Ltd | Director | Grant | A | 0.98 | 6,377,383 | 6,217,948 | 12,754,766 | 6.4 M to 12.8 M (+100.00 %) |
Jun 25 2018 | ONS | Oncobiologics, Inc ... | GMS Tenshi Holdings Pte. Ltd | Director | Grant | A | 0.98 | 6,377,383 | 6,217,948 | 6,377,383 | 0 to 6.4 M |
Jun 19 2018 | ONS | Oncobiologics, Inc ... | MCANDREW STEPHEN J | SVP Bus. Strat. & D ... | Option Exercise | A | 0.90 | 30,000 | 27,000 | 30,000 | |
Apr 17 2018 | ONS | Oncobiologics, Inc ... | THURMAN RANDY H | Director | Option Exercise | A | 0.92 | 25,000 | 23,000 | 25,000 | |
Mar 27 2018 | ONS | Oncobiologics, Inc ... | Windisch Joerg | Director | Option Exercise | A | 0.94 | 25,000 | 23,500 | 25,000 | |
Jan 05 2018 | ONS | Oncobiologics, Inc ... | Mohan Pankaj | President & CEO | Sell | S | 1.16 | 62,569 | 72,580 | 7,056,553 | 7.1 M to 7.1 M (-0.88 %) |
Jan 05 2018 | ONS | Oncobiologics, Inc ... | Mohan Pankaj | President & CEO | Sell | S | 1.18 | 52,108 | 61,487 | 7,119,122 | 7.2 M to 7.1 M (-0.73 %) |
Dec 26 2017 | ONS | Oncobiologics, Inc ... | Yamashita Elizabeth A. | VP, Regulatory Affa ... | Sell | S | 1.13 | 16,170 | 18,272 | 64,648 | 80.8 K to 64.6 K (-20.01 %) |